CEACAM5 and pachyonychia congenita: Currently available tumor markers of PC, carcinoembryonic antigen (CEA) and CA 19-9, exhibit low sensitivity and specificity for PC diagnosis, and they are particularly unsatisfactory for early detection of this disease.